BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

RegeneRx Biopharmaceuticals, Inc. 

3 Bethesda Metro Center, Suite 630

Bethesda  Maryland  20814  U.S.A.
Phone: 301-280-1992 Fax: 301-280-1996


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 10/24/2014 9:23:31 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: Dr. Michael Chopp Reports On Successful Remodeling Of The Central And Peripheral Nervous Systems After Injury/Disease Using Thymosin Beta 4 10/23/2014 11:28:09 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Allowed To Proceed With Phase 3 Using RGN-259 Eye Drops For The Treatment Of Neurotrophic Keratopathy 10/20/2014 8:27:43 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Canadian Patent For Inhibition Or Reversal Of Skin Aging 9/30/2014 9:16:22 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives $1 Million Pursuant To Product License And Stock Purchase Agreement 9/3/2014 12:06:40 PM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: New Report: Thymosin ?4 Prevents Heart Rupture & Improves Cardiac Function After Heart Attack In Mice 7/15/2014 7:32:01 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX)’s Strategic Partner G-Treebnt Preparing For Phase 3 Dry Eye Trials In Asia With RGN-259 7/7/2014 10:16:00 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Release: Chinese FDA Accepts Phase 2 IND For RGN-259 For Dry Eye 6/23/2014 11:45:39 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Issues Letter To Shareholders 5/22/2014 8:04:12 AM
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives $1.35 Million Pursuant To Product License And Stock Purchase Agreement 3/31/2014 8:36:57 AM
12345678910...